부산대학교 도서관

Epstein-Barr virus (EBV) infection, whether reactivation of a dormant infection or newly acquired, is a major driver behind lymphoproliferative disorders that have the potential of evolving to full-blown lymphoma if not managed properly, especially in an immunosuppressed host. [1][7] Early detection of PTLD involves monitoring transplant recipients for signs of the disease, testing for EBV infection, and adjusting immunosuppressive therapy as necessary. 2 Representation of the intricate relationships between infection, immunity, and cancer that an Epstein-Barr virus (EBV) infection may uncover. [Extracted from the article]